Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study
- PMID: 31802314
- PMCID: PMC6938472
- DOI: 10.1007/s11060-019-03341-6
Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study
Abstract
Purpose: Deficits in neurocognitive functioning (NCF) frequently occur in glioma patients. Both treatment and the tumor itself contribute to these deficits. In order to minimize the harmful effects of surgery, an increasing number of patients undergo awake craniotomy. To investigate whether we can indeed preserve cognitive functioning after state-of-the art awake surgery and to identify factors determining postoperative NCF, we performed a retrospective cohort study.
Methods: In diffuse glioma (WHO grade 2-4) patients undergoing awake craniotomy, we studied neurocognitive functioning both pre-operatively and 3-6 months postoperatively. Evaluation covered five neurocognitive domains. We performed analysis of data on group and individual level and evaluated the value of patient-, tumor- and treatment-related factors for predicting change in NCF, using linear and logistic regression analysis.
Results: We included 168 consecutive patients. Mean NCF-scores of psychomotor speed and visuospatial functioning significantly deteriorated after surgery. The percentage of serious neurocognitive impairments (- 2 standard deviations) increased significantly for psychomotor speed only. Tumor involvement in the left thalamus predicted a postoperative decline in NCF for the domains overall-NCF, executive functioning and psychomotor speed. An IDH-wildtype status predicted decline for overall-NCF and executive functioning.
Conclusions: In all cognitive domains, except for psychomotor speed, cognitive functioning can be preserved after awake surgery. The domain of psychomotor speed seems to be most vulnerable to the effects of surgery and early postoperative therapies. Cognitive performance after glioma surgery is associated with a combination of structural and biomolecular effects from the tumor, including IDH-status and left thalamic involvement.
Keywords: Brain tumor; Determinants of neurocognitive functioning; Glioma; Neurocognitive functioning changes; Neuropsychology.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment.Neurooncol Pract. 2019 Dec;6(6):463-472. doi: 10.1093/nop/npz008. Epub 2019 Apr 22. Neurooncol Pract. 2019. PMID: 31832216 Free PMC article.
-
Association between tumor location and neurocognitive functioning using tumor localization maps.J Neurooncol. 2019 Sep;144(3):573-582. doi: 10.1007/s11060-019-03259-z. Epub 2019 Aug 13. J Neurooncol. 2019. PMID: 31410731
-
Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.Neurosurgery. 2021 Feb 16;88(3):544-551. doi: 10.1093/neuros/nyaa453. Neurosurgery. 2021. PMID: 33080024 Free PMC article.
-
Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.J Neurooncol. 2017 Aug;134(1):9-18. doi: 10.1007/s11060-017-2503-z. Epub 2017 May 31. J Neurooncol. 2017. PMID: 28567586 Free PMC article. Review.
-
Is non-awake surgery for supratentorial adult low-grade glioma treatment still feasible?Neurosurg Rev. 2018 Jan;41(1):133-139. doi: 10.1007/s10143-017-0918-9. Epub 2017 Nov 6. Neurosurg Rev. 2018. PMID: 29105013 Review.
Cited by
-
Verbal fluency predicts work resumption after awake surgery in low-grade glioma patients.Acta Neurochir (Wien). 2024 Feb 19;166(1):88. doi: 10.1007/s00701-024-05971-w. Acta Neurochir (Wien). 2024. PMID: 38372820
-
Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas.Croat Med J. 2023 Dec 31;64(6):383-390. doi: 10.3325/cmj.2023.64.383. Croat Med J. 2023. PMID: 38168519 Free PMC article.
-
Neuropsychological impairment in primary malignant brain tumor patients with awake craniotomy: a hospital-based registration study.J Neurooncol. 2023 Sep;164(2):483-491. doi: 10.1007/s11060-023-04431-2. Epub 2023 Sep 5. J Neurooncol. 2023. PMID: 37668943
-
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors.Int J Mol Sci. 2023 Jun 26;24(13):10669. doi: 10.3390/ijms241310669. Int J Mol Sci. 2023. PMID: 37445846 Free PMC article. Review.
-
Cognitive functioning in a cohort of high-grade glioma patients.Radiol Oncol. 2023 Jun 21;57(2):201-210. doi: 10.2478/raon-2023-0009. eCollection 2023 Jun 1. Radiol Oncol. 2023. PMID: 37341199 Free PMC article.
References
-
- van Kessel E, Baumfalk AE, van Zandvoort MJE, Robe PA, Snijders TJ. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment. J Neurooncol. 2017;134(1):9–18. doi: 10.1007/s11060-017-2503-z. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
